Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07817147
NA

CREO - Microwave Ablation Feasibility Study

Sponsor: Banner Health

View on ClinicalTrials.gov

Summary

The goal of this study is to assess the overall success of energy delivery during treatment using the ultrasound guided microwave ablation device in patients with locally advanced, unresectable, or metastatic cancer. Secondly, this study aims to explore the procedural/clinical safety of treatment with the device and the antitumor effect following treatment with the device.

Official title: Investigator-Initiated Feasibility Study of a Novel Endoscopic Ultrasound Guided Microwave Ablation Device in Patients With Locally Advanced, Unresectable, or Metastatic Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

75

Start Date

2026-02-19

Completion Date

2028-08

Last Updated

2026-09-14

Healthy Volunteers

No

Interventions

DEVICE

EUS-Guided MWA Device

The rationale of this study is to generate preliminary data on the functionality and safety of Creo's MicroBlate™ Fine device when used under EUS guidance. The results generated from this study will inform any decisions regarding subsequent pivotal trials and may support the integration of this approach into clinical practice for anatomically challenging tumors.

Locations (7)

Banner MD Anderson Cancer Center and Gateway Hospital

Gilbert, Arizona, United States

Cedars Sinai

Los Angeles, California, United States

Rush University Medical Center

Chicago, Illinois, United States

Mayo Clinic Rochester

Rochester, Minnesota, United States

University of Tennessee Medical

Knoxville, Tennessee, United States

Memorial Hermann-Texas Medical Center

Houston, Texas, United States

West Virginia University Medicine

Morgantown, West Virginia, United States